Literature DB >> 24752869

The influence of the metabolic syndrome on atrial fibrillation occurrence and outcome after coronary bypass surgery: a 3-year follow-up study.

Branislava Ivanovic1, Marijana Tadic2, Zeljko Bradic3, Nevenka Zivkovic1, Dejana Stanisavljevic4, Vera Celic4.   

Abstract

BACKGROUND: We sought to investigate the influence of the metabolic syndrome (MS) on new-onset postoperative atrial fibrillation (POAF), and occurrence of major adverse cardiovascular and cerebrovascular events (MACCE) in a period of 3 years after isolated coronary artery bypass grafting (CABG) surgery.
METHODOLOGY: The study included 460 patients who underwent the first CABG operation without baseline atrial fibrillation. The MS was defined by the presence of three or more Adult Treatment Panel (ATP)-American Heart Association (AHA)- National Heart, Lung, and Blood (NHLB) Institute criteria. POAF was diagnosed by continuous electrocardiographic monitoring during the first 48 to 72 hours after CABG. All the patients were followed up for at least 3 years after surgery.
RESULTS: The MS and its criteria were significantly associated with POAF and MACCE occurrence in the 3-year period after isolated CABG surgery. Among the MS risk factors, hypertension, abdominal obesity, and the increased fasting glucose level were independently associated with both POAF and MACCE onset in the observed patients. Individuals with four or five MS criteria have similar risk of POAF or MACCE as individuals with three MS criteria. In the 3-year period of follow-up, the MS was proven to be associated with MACCE occurrence, independently of hypertension, diabetes, and obesity defined by body mass index.
CONCLUSIONS: The MS and its criteria significantly increased risk of POAF and MACCE in a 3-year period. The MS, irrespective of hypertension, diabetes, and obesity, was associated with POAF and MACCE in the patients who underwent CABG. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24752869     DOI: 10.1055/s-0034-1372349

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  7 in total

1.  Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease.

Authors:  Arwa Younis; Anan Younis; Boaz Tzur; Yael Peled; Nir Shlomo; Ilan Goldenberg; Enrique Z Fisman; Alexander Tenenbaum; Robert Klempfner
Journal:  Cardiovasc Diabetol       Date:  2016-10-28       Impact factor: 9.951

2.  Effects of metabolic syndrome with or without obesity on outcomes after coronary artery bypass graft. A cohort and 5-year study.

Authors:  Hushan Ao; Fei Xu; Xianqiang Wang; Xinran Tang; Zhe Zheng; Shengshou Hu
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

3.  Impact of metabolic syndrome on mortality and morbidity after coronary artery bypass grafting surgery.

Authors:  Maryam Ardeshiri; Zahra Faritus; Zahra Ojaghi-Haghighi; Hooman Bakhshandeh; Faranak Kargar; Rokhsareh Aghili
Journal:  Res Cardiovasc Med       Date:  2014-08-05

4.  Predictors of new-onset atrial fibrillation in elderly patients with coronary artery disease after coronary artery bypass graft.

Authors:  Rubanenko O Anatoĺevna; Fatenkov O Veniaminovich; Khokhlunov S Mikhaylovich
Journal:  J Geriatr Cardiol       Date:  2016-07       Impact factor: 3.327

5.  New-Onset Atrial Fibrillation After Coronary Artery Bypass Graft and Long-Term Risk of Stroke: A Meta-Analysis.

Authors:  Matthew R Megens; Leonid Churilov; Vincent Thijs
Journal:  J Am Heart Assoc       Date:  2017-12-22       Impact factor: 5.501

6.  Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease.

Authors:  Arwa Younis; Ronen Goldkorn; Ilan Goldenberg; Diklah Geva; Boaz Tzur; Anna Mazu; Anan Younis; Zvi Fisman; Alexander Tannenbaum; Robert Klempfner
Journal:  J Am Heart Assoc       Date:  2017-10-27       Impact factor: 5.501

7.  Dose-response relationship among body mass index, abdominal adiposity and atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of 35 cohorts.

Authors:  Menglu Liu; Kaibo Mei; Lixia Xie; Jianyong Ma; Peng Yu; Siquan Niu; Ya Xu; Yujie Zhao; Xiao Liu
Journal:  PeerJ       Date:  2021-07-21       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.